Key Words mental retardation, trinucleotide repeat, RNA binding, dendritic spine, synaptic plasticity s Abstract Fragile X syndrome is one of the most common forms of inherited mental retardation. In most cases the disease is caused by the methylation-induced transcriptional silencing of the fragile X mental retardation 1 (FMR1) gene that occurs as a result of the expansion of a CGG repeat in the gene's 5 UTR and leads to the loss of protein product fragile X mental retardation protein (FMRP). FMRP is an RNA binding protein that associates with translating polyribosomes as part of a large messenger ribonucleoprotein (mRNP) and modulates the translation of its RNA ligands. Pathological studies from the brains of patients and from Fmr1 knockout mice show abnormal dendritic spines implicating FMRP in synapse formation and function. Evidence from both in vitro and in vivo neuronal studies indicates that FMRP is located at the synapse and the loss of FMRP alters synaptic plasticity. As synaptic plasticity has been implicated in learning and memory, analysis of synapse abnormalities in patients and Fmr1 knockout mice should prove useful in studying the pathogenesis of fragile X syndrome and understanding learning and cognition in general.
INTRODUCTION
Evidence that mental retardation has a sex-linked component came as early as the turn of the twentieth century. In the population at large and in prison populations, Johnson (1897) , Penrose (1938) , and others found an excess of males with mental retardation compared to females (reviewed in Lehrke 1974) . At the time, this preponderance of males was thought to be due to ascertainment bias because males were more likely to be institutionalized and the expectations placed upon them by society were higher. There was evidence of an excess of males with high IQ, of an excess of retarded male sibships, and that the IQ of the mother has more effect on mental retardation in sons than does the IQ of the father. These data led Lehrke (1974) to argue that genes affecting intelligence are located on the X chromosome and to estimate that one fourth of mental retardation can be traced to X-linked factors. Indeed, as early as 1943, a pedigree reported by Martin & Bell showed mental retardation segregating as an X-linked recessive gene, and many others showed the same (Losowsky 1961 , Dunn et al. 1963 , Lubs 1969 . Lubs (1969) noticed a peculiar chromosomal variant that segregated with mental retardation over three generations. He described a constriction near the end of the long arm of the X chromosome apparent in metaphase spreads from four mentally retarded males and one normal female. This variant would later be localized to Xq27.3 (Harrison et al. 1983 ) and become known as a fragile X chromosome. Some early studies confirmed the link between the fragile X and mental retardation (Giraud et al. 1976 , Harvey et al. 1977 , but many others were negative. Sutherland (1977 Sutherland ( , 1979 showed that culture media deficient in folic acid and thymidine are required for fragile site expression. He called for repetition of previous cytological studies of families with X-linked mental retardation. Males from the original Martin & Bell pedigree were found to express the fragile site (Richards et al. 1981) , and mental retardation associated with a fragile X chromosome was then termed the Martin-Bell syndrome, now known as fragile X syndrome.
With the advent of a cytogenetic marker for some cases of X-linked mental retardation, and as a number of families with the fragile X chromosome were identified, the syndromic nature of the disorder became more apparent. Studies in the late 1970s and 1980s led to the current clinical picture of fragile X syndrome. The primary attributes of an affected male are moderate to severe mental retardation (Bennetto & Pennington 1996) , macroorchidism (Turner et al. 1980) , and a connective tissue dysplasia leading to a characteristic yet mild physical appearance of a long, narrow face and large ears (Opitz et al. 1984 , Hagerman et al. 1984 . Other clinical signs, presumably due to the connective tissue disorder, include velvet-like skin, finger-joint hyperextensibility, recurrent otitis media, aortic root dilatation, and mitral valve prolapse (Loehr 1986 , Hagerman 1996 . Patients often display autistic features ranging from shyness, poor eye contact, and social anxiety in less affected individuals to hyperactivity, hand flapping, hand biting, and perserverative speech in the severely affected (Merenstein et al. 1996) , as well as seizures and EEG findings consistent with epilepsy (Musumeci et al. 1999 , Sabaratnam et al. 2001 . Some obligate carrier women are also affected (Nielsen et al. 1981 , Fryns 1986 , Hagerman et al. 1992 . In general, affected females have a less severe phenotype than do males, and the severity of dysfunction is correlated to the degree of X-inactivation on the abnormal chromosome (Abrams et al. 1994 .
Along with the existence of affected females heterozygous for the fragile X, a number of pedigrees also show unaffected males who transmit the marker to their daughters (Martin & Bell 1943 , Losowsky 1961 , Nielsen et al. 1981 . These two results point to a mode of inheritance more complicated than a simple X-linked recessive model. Because of these irregularities in the set of reported pedigrees, 317 Sherman et al. (1984 Sherman et al. ( , 1985 performed a large-scale segregation analysis on 206 fragile X syndrome pedigrees. They too saw a significant number of asymptomatic males and affected females and put forward a model of X-linked dominant inheritance with reduced penetrance (79% for males and 35% for females). Sherman et al. also noted the lack of sporadic cases and thus argued that each affected male received the gene from his mother. Finally, they noticed that an asymptomatic carrier male is more likely to have grandsons with the disorder than to have brothers with the disorder. Therefore, the penetrance for the disease increases in succeeding generations of a pedigree-an observation referred to as the Sherman paradox. The mechanism responsible for the Sherman paradox became clear in 1991 with the cloning of the gene defective in fragile X syndrome.
FMR1
Before the gene responsible for fragile X syndrome could be cloned, a great deal of both genetic and physical mapping was done. Although the fragile site cosegregated with the syndrome phenotype, it was unknown whether or not the syndrome was caused by the fragile site itself or a closely linked causal mutation. Pedigree analysis localized both the causal locus and the fragile site to a 22 cM region on the X chromosome between the factor IX gene and marker St14 (Oberle et al. 1986) , and further studies revealed a number of linked markers that reduced the interval to 1-2 Mb and strengthened the localization of the disease locus to the fragile site (Suthers et al. 1989 (Suthers et al. , 1990 Hirst et al. 1991; Rousseau et al. 1991) . Warren et al. (1987 Warren et al. ( , 1990 ) devised a method using somatic cell hybrid lines to mark the fragile site itself by selecting for X chromosome breakage and translocation generated when the fragility was induced.
Methylation-sensitive restriction fragment digests separated by pulsed-field gel electrophoresis and probed with markers flanking the fragile site identified a region methylated in fragile X patients but not in unaffected carriers or normal males (Vincent et al. 1991 , Bell et al. 1991 . Furthermore, fragments abnormally methylated in affected individuals were found to be unstable and to increase in size when transmitted through a pedigree . Heitz et al. (1991) identified a yeast artificial chromosome (YAC) containing two markers known to flank the fragile site hybrid breakpoints and showed that this YAC contains a CpG island aberrantly methylated in fragile X patients. Finally, Verkerk et al. (1991) independently used the same YAC to probe a human brain cDNA library and clone the gene responsible for the disease: fragile X mental retardation 1 (FMR1). Expression of FMR1 is absent in the majority of fragile X patients , and the number of patients with FMR1 deletions proves the syndrome is caused by the loss of FMR1 function (Gedeon et al. 1992 , Wohrle et al. 1992 .
The gene itself spans 38 kb and encodes a 4.4 kb transcript consisting of 17 exons ( Figure 1A ) (Eichler et al. 1993 , Ashley et al. 1993a . FMR1
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O'DONNELL WARREN has two autosomal paralogs (FXR1 and FXR2; Siomi et al. 1995 , Zhang et al. 1995 and highly conserved orthologs in mammals, chickens, and fruit flies (Ashley et al. 1993a , Price et al. 1996 , Wan et al. 2000 . Full-length fragile X mental retardation protein (FMRP), the protein encoded by FMR1, has a molecular weight of 69 kDa, but extensive alternate splicing of exons produces a number of protein isoforms (Eichler et al. 1993 , Ashley et al. 1993a ; the structure and function of FMRP are discussed below). Consistent with the primary features of the phenotype, FMR1 mRNA and protein are highly expressed in testis and in fetal and adult brain, with the majority of signal localized to neurons (Abitbol et al. 1993 , Devys et al. 1993 . FMR1 harbors a novel, dynamic mutation that accounts for both the fragile site and the genetic peculiarities observed to be associated with the region.
Both the hybrid breakpoints and the unstable DNA fragments map to a (CGG) n repeat , Verkerk et al. 1991 , later shown to be in the 5 untranslated region of FMR1 (Ashley et al. 1993a ). The repeat is polymorphic in the general population with a range of 6-60 and a mode of 30 , Snow et al. 1993 . Examination of fragile X pedigrees reveals two other classes of alleles: nonpenetrant premutations with 60-200 repeats and completely penetrant full mutations with >200 repeats, which often are in the thousands ( Figure 1B ) , Snow et al. 1993 . Premutation alleles are unstable and tend to expand when transmitted. A premutation can undergo a small expansion to another, usually slightly larger allele in the premutation range, or it can undergo massive expansion to a full mutation. This massive expansion to a full mutation occurs only when the premutation is transmitted from a female with male spermatogenesis apparently unable to maintain the long full-mutation repeat (Malter et al. 1997) . Furthermore, the risk of expansion to the full mutation is determined by the size of the premutation: The larger the premutation is, the more likely it will expand to the full mutation. Because premutations increase through a pedigree, the risk of expansion to full mutation also increases-an observation that resolves the Sherman paradox (Fu et al. 1991 , Heitz et al. 1992 .
Massive CGG expansion is the causative mutation in >95% of patients with fragile X syndrome (Warren & Sherman 2001) . As a result of expansion, the repeat and the upstream CpG island are methylated, and FMR1 expression is silenced , Sutcliff et al. 1992 , Hornstra et al. 1993 ). Treatment of fullmutation cell lines with methylation inhibitors reactivates a low level of FMR1 expression, which indicates that methylation causes the gene silencing (Chiurazzi et al. 1998) . Methyl-C binding protein MeCP2 binds to methylated DNA and recruits histone deacetylases. These deacetylases induce chromatin condensation and prevent transcription machinery from binding to a gene's promoter (Razin 1998) . Indeed, the association of acetylated histones with FMR1 is reduced in fullmutation cell lines and is restored with methylation inhibitor treatment (Coffee et al. 1999) . Furthermore, treatment of full-mutation lines with histone deacetylase inhibitors along with methylation inhibitors reactivates the normally silent FMR1 more than does treatment with methylation inhibitors alone (Chiurazzi et al. 1999) . However, treatment with histone deacetylase inhibitors alone induces little 319 or no increase in gene expression, which indicates that at least to some extent methylation alone is sufficient for gene silencing. In vivo footprinting analysis of the FMR1 promoter region shows a number of putative transcription factor binding sites that are protected in normal cells but are absent in methylated patient cell lines (Schwemmle et al. 1997 , Drouin et al. 1997 . Kumari & Usdin (2001) have shown that transcription factors USF1, USF2, and alpha-Pal/Nrf-1 bind to the FMR1 promoter and are required for reporter gene expression driven by the FMR1 promoter. Methylating the reporter constructs suppresses gene expression, but not fully. Thus, it appears that both histone-dependent and histone-independent effects are at work in methylation-dependent gene silencing at the FMR1 promoter. Though it may appear that reactivation of FMR1 in patients is an ideal approach to therapy, current data suggest translation of FMRP is suppressed in large fullmutation transcripts (Feng et al. 1995) . Thus, reactivating transcription may not appreciably increase cellular FMRP levels.
Repeat Expansion
The elucidation of the exact timing and mechanism for both modest and massive expansions of premutation alleles has been a major goal in fragile X research over recent years. Initially, the findings of somatic mosaicism in repeat size in full-mutation males and of the absence of full-mutation alleles in the sperm of those males led to a model of postzygotic expansion occurring after germline differentiation , Reyniers et al. 1993 ). However, Moutou et al. (1997) argues that in this postzygotic model, the degree of mosaicism should be inversely proportional to the length of maternal premutation; this prediction, in fact, is not the case. Thus, the mosaicism seen in full-mutation patients is likely due to variable contraction of somatic full-mutation alleles and not variable expansion of maternal premutation alleles. More support of a prezygotic model came from studies of fetal gonadal tissue. Malter et al. (1997) found only full-mutation alleles in the ovaries of a 16-week-old fetus, which suggests that the timing of expansion must be before germline differentiation. Furthermore, testis tissue from a 13-weekold full-mutation fetus showed only full mutations in the germ cells while testis tissue from an older fetus showed evidence of both full and premutations in the germ cells (Malter et al. 1997 ). These observations, taken together with the lack of full-mutation alleles in adult sperm, led Malter and his colleagues to argue that spermatogenesis is unable to maintain full mutations. Similar conclusions were reached for myotonic dystrophy, a disease in which males do not transmit long CTG repeats (Jansen et al. 1994) . While these studies point to a prezygotic expansion, expansion occurring very early in embryogenesis (before day 3-5) cannot be ruled out (Malter et al. 1997 , Moutou et al. 1997 . To definitively time the expansion, repeat lengths in the oocytes of premutation females must be measured to determine if expansion occurs during oogenesis-a difficult prospect in humans. It is clear that animal models for expansion will be essential to determine both the timing and the mechanism of expansion.
For the most part, attempts to recapitulate expansion in the mouse have been ineffective (Bontekoe et al. 1997; Lavedan et al. 1997 Lavedan et al. , 1998 . While some modest expansions have recently been reported in a mouse containing a human (CGG) 98 repeat recombined into the endogenous mouse Fmr1 locus (Bontekoe et al. 2001) , to date there are no reports of massive expansion occurring in the mouse. It will be interesting to see if the repeat in the mice of Bontekoe and colleagues continues to expand with time and eventually reaches a threshold for massive expansion. Though the lack of a good animal model for expansion is disappointing, the apparent stability of the CGG repeat in mouse should prove useful in identifying both cis and trans acting factors in the mechanism of expansion. The loss of repeat stability in knockin mice generated with increasing amounts of human FMR1 sequence can be used as an assay for factors that influence the repeat in cis, and mutational analysis may identify genes expressed in the mouse and not humans that when mutated alter the stability of premutation-sized alleles.
Studies in humans tend to point to the structure of the repeat itself as the most important variable in expansion, although certain haplotypes of polymorphic markers in and around the FMR1 locus are overabundant in fragile X chromosomes, which indicates the possibility of other cis acting sequences (Eichler et al. 1996 , Gunter et al. 1998 . Single AGG triplets that are variable in both number and location interrupt the CGG repeat of FMR1 in normal chromosomes (Verkerk et al. 1991 , Kunst & Warren 1994 . The ancestral sequence is 5 -(CGG) 9 AGG(CGG) 9 AGG(CGG) 9 -3 (Eichler et al. 1995) , and variation of repeat length occurs almost exclusively at the 3 end of the repeat (Kunst & Warren 1994 , Eichler et al. 1994 . Furthermore, the length of pure CGG tracts predicts repeat stability with a threshold for expansion of 34-38 uninterrupted repeats. Unstable premutations arise either from the gradual expansion of the 3 end or by the loss of one or more AGG interruptions (Eichler et al. 1996) .
The polarity of expansion of the CGG repeat in humans mimics the orientationdependent instability of CGG repeats cloned into E. coli and S. cerevisiae (Hirst & White 1998 , White et al. 1999 ). This finding suggests that a difference in leadingversus lagging-strand synthesis may be involved in repeat expansion. Because trinucleotide repeats have been shown to form secondary structures whose stability increases with length and decreases with AGG interruption (Gacy et al. 1995 , Gacy & McMurray 1998 , Pearson et al. 1998 ), many models for repeat expansion evoke hairpin formation and subsequent slippage during replication. One model for repeat expansion that is rapidly gaining acceptance involves the abnormal processing of repeat containing Okazaki fragments during lagging strand synthesis (Gordenin et al. 1997) . During normal replication, the synthesis of the newly formed, upstream Okazaki fragment displaces the 5 end of the downstream fragment to facilitate RNA primer removal by FEN1 endonuclease (Budd et al. 1995 , Budd & Campbell 1997 . If the downstream Okazaki fragment was initiated in the repeat, the displaced strand could fold back upon itself and form a stable secondary structure. The ability of FEN1 to cleave these secondary structures is reduced and is inversely proportional to the length of the foldback (Henricksen et al. 2000) .
Supporting this model, yeast mutant for RAD27, the ortholog of FEN1, show a tenfold increase in repeat expansion (White et al. 1999 ).
Prevalence and the Premutation Revisited
With the discovery of the causal, dynamic mutation in FMR1, a more sensitive and specific DNA-based test supplanted cytology in the diagnosis of fragile X syndrome . Numerous studies have found fragile X syndrome in every ethnic group, with current estimates putting the prevalence at 1 out of 4500 males and 1 out of 9000 females (reviewed in Warren & Sherman 2001) . With the advent of a DNA-based diagnostic test, the study of premutation carriers has increased. The prevalence of the premutation is estimated to be 1 out of 1000 males and 1 out of 400 females, consistent with the dynamic nature of the mutation (Warren & Sherman 2001) . Some premutation individuals are not truly unaffected, as once thought, but exhibit subtle fragile X-like features (Hull & Hagerman 1993 , Loesch et al. 1994 , Riddle et al. 1998 ) as well as premature ovarian failure in females and Parkinsonism in elderly males (Allingham-Hawkins et al. 1999 , Uzielli et al. 1999 , Hagerman et al. 2001 . These latter two features are remarkable in that they are unique to the premutation, as full-mutation individuals are not affected. Premutation carriers express FMR1 mRNA at higher levels and FMRP at lower levels than do normal controls (Tassone et al. 2000 , Kenneson et al. 2001 ). This observation led to the suggestion that higher level of FMR1 mRNA may be responsible for the unique features in premutation individuals (Tassone et al. 2000) .
FROM GENOTYPE TO PHENOTYPE: THE CAUSE OF COGNITIVE IMPAIRMENT IN FRAGILE X SYNDROME
As the primary characteristic of fragile X syndrome is mental retardation, an obvious point of focus for much of the work over the past years is how the loss of FMRP leads to abnormal cognitive function. Studies addressing this issue include: (a) anatomical ones using cadaveric tissue as well as CT and MRI images from affected patients to more fully characterize the fragile X phenotype, (b) the creation and characterization of a mouse model for the syndrome that is amenable to more rigorous laboratory manipulation than are human models, (c) biochemical studies to determine the function of FMRP, and (d ) studies to determine how loss of FMRP function in neurons leads to cognitive impairment.
Anatomical Studies
Brains taken at autopsy from a total of six fragile X males show no gross abnormalities (Rudelli et al. 1985 , Hinton et al. 1991 , Irwin et al. 2001 ). Brain weight and structure appear normal with the exception of mild cortical atrophy in one patient and ventricular enlargement in four. CT scanning confirmed this ventricular enlargement in seven of eight live patients . In a number of studies comparing MRI images of fragile X patients with those of normal controls, Reiss and his colleagues have not only confirmed the increase of lateral ventricular volume (Reiss et al. 1995 , Eliez et al. 2001 ), but also have revealed a number of other, somewhat subtle structural differences in patients. In both male and female patients, the posterior vermis of the cerebellum is decreased (Reiss et al. 1991a ,b, Mostofsky et al. 1998 ) and the caudate nucleus is increased (Reiss et al. 1995 , Eliez et al. 2001 . Furthermore, the posterior vermis, caudate nucleus, and lateral ventricle volumes appear to correlate with cognitive function, and the authors suggest that the vermis and caudate sizes correlate with FMR1 expression, which indicates that the observed anatomical differences in patients are due to the lack of FMRP (Reiss et al. 1995 , Mostofsky et al. 1998 ). Reiss also found the hippocampus to be enlarged in fragile X children and young adults (Reiss et al. 1994 , Kates et al. 1997 ), but Jakala et al. (1997) did not reproduce this finding in adults. The difference in size of all of these structures is small, however, and there is substantial overlap in each case between controls and patients.
Though it is tempting to speculate on how these changes relate to the neurological deficits seen in fragile X syndrome, it is important to remember that while these descriptive studies point to structures that may be involved in the syndrome, they cannot address whether any anatomical change is causative for-or is merely caused by-the neurological deficits seen in patients. The anatomical studies also do not begin to address a molecular mechanism for the cognitive dysfunction seen in patients-to do so requires the study of the neurons themselves. The limitations to performing such research in the brains of humans require that an animal model be developed to further the neurobiological research into FMRP.
The FMRP Knockout Mouse
Though the need for a mouse model for fragile X syndrome is unquestionable, the validity and applicability of any animal model must be examined. FMR1 is highly conserved between human and mouse with a nucleotide and amino acid identity of 95% and 97% respectively, including the CGG repeat in the 5 UTR (Ashley et al. 1993a) . Furthermore, in situ hybridization and Fmr1: β-galactosidase transcriptional fusion experiments have shown the expression pattern of murine Fmr1 to be similar to the human version in both tissue specificity and time of expression (Hinds et al. 1993 , Hergersberg 1995 . Finally, though the mouse repeat does not appear to undergo expansion and thus cannot mimic the timing of methylation and inactivation of FMR1 seen in humans, the existence of deletion and point mutations patients with fragile X syndrome shows that the lack of FMRP throughout development is sufficient to cause the phenotype. Thus, because the knockout animal never has functional FMRP, it should provide an accurate molecular model for the human condition.
With this reasoning in mind, a consortium of the Oostra and Willems labs created an Fmr1 knockout mouse by the insertion of a neomycin cassette into exon 5 of the murine gene (Dutch-Belgian Fragile X Consortium 1994). This mouse 323 has no functional FMRP in any of the tissues assayed by Western blotting. As with the human syndrome, the phenotype of the mutant mouse is mild: No major neurological deficits are found, no obvious abnormalities of the major organ systems are revealed by pathological examination, and reproductive fitness is not reduced. Also consistent with the human disease, adult mutant mice show significant macroorchidism, undergo audiogenic seizures, and exhibit subtle behavioral abnormalities (Dutch-Belgian Fragile X Consortium 1994, Musumeci et al. 2000 , Chen & Toth 2001 . While it is impossible to give mice the equivalent of an IQ test, a number of paradigms have been designed that test different aspects of cognition and behavior in mice (Crawley & Paylor 1997) . With these paradigms, Fmr1 knockout mice exhibit increased exploratory and motor activity, deficits in spatial learning ability, and decreased anxiety-related responses (Dutch-Belgian Consortium 1994 , D'Hooge et al. 1997 , Van Dam et al. 2000 , Peier et al. 2000 , although there has been some difficulty replicating these results owing to possible strain-dependent effects (Paradee et al. 1999 , Fisch et al. 1999 . The creation of an Fmr1 knockout mouse that has phenotypic characteristics consistent with the human disease has proven valuable for the functional and neurophysiologic studies performed in order to zero in on the cause of fragile X syndrome.
Biochemical Studies
Because the lack of functional FMRP is both necessary and sufficient for the development of fragile X syndrome, elucidation of the function of FMRP in normal cells is imperative for understanding the pathogenesis of the disease. FMRP has functional domains in common with proteins known to form large ribonucleoprotein (RNP) complexes in vivo. By sequence analysis, Siomi et al. (1993b) and Ashley et al. (1993b) independently identified three RNA binding domains in FMRP: two KH domains (KH1, KH2) that show homology to hnRNP K (Siomi et al. 1993a) , and an RGG box similar to hnRNP U (Kiledjian & Dreyfuss 1992) . Both in vitro translated and purified FMRP bind RNA homopolymers and 4% of fetal brain messages in vitro, which confirms that FMRP is indeed an RNA binding protein (Siomi et al. 1993b , Ashley et al. 1993b , Brown et al. 1998 ). Recent studies have identified both the in vivo ligands of FMRP and the RNA motif to which FMRP binds. In vitro, the RGG box of FMRP binds strongly to an intramolecular stemloop structure that is termed a G-quartet (Figure 2) (Schaeffer et al. 2001 , Darnell et al. 2001 . Furthermore, this G-quartet is found in approximately 70% of transcripts that immunoprecipitate with FMRP, which indicates this structure is indeed the in vivo target for FMRP binding (Brown et al. 2001 ).
When FMRP is sedimented through sucrose gradients, it associates with translating polyribosomes as part of a large mRNP complex (Eberhart et al. 1996 , Khandjian et al. 1996 , Corbin et al. 1997 , Feng et al. 1997a ). This mRNP is >660 kDa in size and contains a number of proteins, including both FMRP autosomal homologs (Feng et al. 1997a , Ceman et al. 1999 . The functional importance of this polyribosome association of FMRP is demonstrated by a severely affected fragile X syndrome patient who has a missense mutation in the KH2 domain of FMRP (De Boulle et al. 1993) . Crystal structure analysis of highly conserved KH domains in other proteins suggests that this isoleucine to asparagine substitution (I304N) compromises the RNA binding ability of the KH2 domain (Musco et al. 1996 , Lewis et al. 2000 . However, absolute RNA binding of the I304N mutant FMRP is not affected (Feng et al. 1997a , Brown et al. 1998 . Instead, the mutant protein no longer associates with translating polyribosomes, but is part of a smaller, abnormal mRNP (Feng et al. 1997a ). Thus, the loss of proper mRNP formation and polyribosome association causes this severe fragile X phenotype in this patient.
325
In the brain, FMRP is located primarily in the cytoplasm of neurons (Devys et al. 1993 ), but a small amount of the protein has been found in the nucleus by both light and electron microscopy (Verheij et al. 1993 , Eberhart et al. 1996 , Feng et al. 1997b ). The study of various FMRP truncation proteins has led to the identification of both a nuclear localization signal and a nuclear export signal in FMRP, leading to the hypothesis that FMRP shuttles into and out of the nucleus (Eberhart et al. 1996) . The paralogs of FMRP (FXR1P and FXR2P) also shuttle into and out of the nucleus, however it appears that unlike FMRP, which shuttles to the nucleoplasm, FXR2P and certain isoforms of FXR1P localize to the nucleolus (Tamanini et al. 1999 (Tamanini et al. , 2000 . Thus, while the FXR proteins are associated in the cytoplasm with FMRP in an mRNP, they may be playing different functional roles in the nucleus. One model of FMRP function taking into account the data discussed above is that FMRP is transported into the nucleus via its nuclear localization signal. Once in the nucleus it associates with a number of other proteins and a distinct population of mRNAs to form an mRNP complex. This complex is then exported to the cytoplasm via the NES, where it associates with ribosomes and influences translation of FMRP ligand mRNAs (Jin & Warren 2000) .
A recent study lends credence to the influence of FMRP on translation. Brown et al. (2001) determined the identities of in vivo mRNA ligands that were selectively immunoprecipitated from mouse brain with the FMRP mRNP. A substantial proportion of these transcripts show a change in translation status by a shift on polyribosome profiles in full-mutation lymphoblastoid cells compared to normal cells. Since in vitro studies have shown that the addition of purified FMRP to translation mixes suppresses translation (Laggerbauer et al. 2001 , Li et al. 2001 , one might expect that cells deficient in FMRP would exhibit increased polysome loading of certain messages. However, Brown et al. observe that both increased and decreased polysome loading of specific messages occurs in fragile X syndrome cells. Clearly the cellular effects are more complex than simple in vitro translation assays; however, one may speculate on the mechanism(s). It is unclear whether all FMRP-containing mRNPs are identical, except for the bound mRNA, or if there are differences in associated proteins among them. If there are distinct FMRP complexes, each may respond differently to the absence of FMRP. Alternatively, it is possible that mRNAs interact with the FMRP complex differently depending upon specific sequence signals on the messages. For example, the RGG domain of FMRP recognizes a G-quartet structure (Darnell et al. 2001) ; the other RNAbinding KH domains of FMRP may recognize a distinct structure. The presence of one or both of these structures may influence the translational fate of specific messages in the absence of FMRP. Finally, the loss of FMRP could simply shift the delicate balance of mRNA translation, so that each message may be regarded as having a variable capacity to be translated and all messages therefore compete with one another for limited ribosome pools. If FMRP indeed suppresses translation, the absence of FMRP could lead to polyribosome loading of normally FMRP-associated messages, competing off ribosomes those messages with less translational attractiveness.
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Neuronal Studies
A neuronal phenotype has been evident in fragile X syndrome since the first autopsy studies by Rudelli et al. (1985) . While neuron counts are normal, qualitative analysis of Golgi-impregnated dendrites in parieto-occipital cortex sections show abnormal dendritic spines-the postsynaptic protrusions from dendrites at which the vast majority of excitatory synapses occur (Harris & Kater 1994) . Spines are sensitive to their environment and change density and morphology to a number of stimuli (Yuste & Bonhoeffer 2001) , and spine abnormalities have long been associated with mental retardation of unknown etiology (Purpura 1974) , as well as with Down's and Rett syndromes (Kaufmann & Moser 2000) . Whether these abnormalities reflect a foundation in the pathogenesis of the mental retardation or are merely a by-product of that mental retardation is not known.
A number of spines in one patient at autopsy were long and thin with prominent heads resembling immature spine-like structures called filopodia (Rudelli et al. 1985) . This observation was confirmed in two other patients (Hinton et al. 1991) and was recently quantified in three additional patients (Irwin et al. 2001) . In studies of sections from the temporal and visual cortex, Irwin and his colleagues found that three adult fragile X males had significantly more long, immature spines and fewer short, mature spines than did controls. Spine density in these patients was also increased compared to control males of the same age, which led the authors to postulate a defect in spine maturation and elimination in fragile X patients. The number of patients studied is still very small and finding adequate controls is nearly impossible, so more studies must be done to address the possibility of other variables causing the observed spine phenotype, as spines are so mutable. For example, the patient in the original study by Rudelli and colleagues was blind for the last 15 years of his life, presented with seizures, and was on antipsychotic medication at the time of his death-all variables that conceivably could alter spine morphology in the cortex independently of FMRP absence. Detailed histories are not provided for the other patients examined, so it remains to be determined whether lack of FMRP is the sole cause of the spine phenotype in those patients.
Spine study results in the Fmr1 knockout mouse, while somewhat conflicting, do support a role for spine abnormalities in fragile X syndrome. In a Golgi impregnation study of layer V pyramidal neurons in sections from the visual cortex of wild-type and Fmr1 knockout mice, Comery et al. (1997) found that spine length and density was increased in knockout dendrites compared to those in wild type. This finding is consistent with the findings in humans and further supports the hypothesis of a maturation and pruning defect. Unfortunately, the studies of Comery et al. were performed on Fmr1 knockout mice that were homozygous for a gene causing retinal degeneration, and thus it is possible a portion of the knockout mice studied were blind. Because slices were taken from the visual cortex, the blindness of the mice may have substantially affected spine phenotype in an FMRP-independent manner. Subsequent studies, comparing congenic littermates to determine the degree of spine phenotype in adult animals related to FMRP, are underway and appear to confirm at least the immaturity if not the increased density of knockout (KO) spines (Irwin et al. 1999 (Irwin et al. , 2000a .
Other studies point to a transient spine phenotype in developing knockout mice. Using two-photon microscopy to visualize enhanced green fluorescence protein EGFP in individual neurons in the barrel region of somatosensory cortex, Nimchinsky et al. (2001) showed that knockouts have significantly longer spines, more long spines, and fewer short spines than do wild-type animals. However, this effect was seen only on postnatal days 7 and 14 and was absent by postnatal day 28. Thus, it appears that in barrel cortex, knockout spines show a transient delay in maturation that resolves with time. Consistent with a transient difference, cultured hippocampal neurons from knockout animals show a similar delay in spine maturation at 14 and 21 days that eventually subsides by 35 days (E. R. Torre, personal communication), and electrophysiology experiments in cultured hippocampal neurons indicate that there is also a delay in establishing synaptic connections that resolves with time (Braun & Segal 2000) .
The spine phenotype in fragile X patients and Fmr1 knockout mice suggests FMRP may be involved in synaptogenesis early in development. One current model of spine formation in synaptogenesis requires initial axon-dendrite contact to occur at filopodia. A subset of these filopodia then becomes mature spines (Dailey & Smith 1996 , Ziv & Smith 1996 , Fiala et al. 1998 . If the long, thin spine-like structures seen in fragile X syndrome are really immature filopodia as their morphology suggests, their prolonged presence could reflect a defect in normal maturation of synapse formation in the absence of FMRP. Even a transient delay may affect the neural circuitry enough to produce the cognitive abnormalities associated with fragile X syndrome. Because the spine phenotype is seen concurrently with the critical period of experience-dependent synapse development in the barrel region (Lendvai et al. 2000) , one intriguing possibility is that the maturational delay seen in knockout spines in the barrel cortex is present at all new synapses. Parallel studies of spine morphology in different brain regions during their critical periods of development as well as denervation/reinnervation experiments would determine the scope of FMRP involvement in spine maturation.
Synaptic plasticity-a long-term change in synaptic strength after stimulationis thought to be the mechanism of information storage in learning and memory (Steward & Schuman 2001) . While the discovery of a spine morphological phenotype indicates a possible defect in synaptic plasticity in fragile X syndrome, altered spine morphology alone does not elucidate a cause of mental retardation. As spines are thought to play a pivotal role in synaptic plasticity, the role of FMRP at the synapse has been a central question. Currently, evidence of FMRP involvement in synaptic plasticity is circumstantial. In vivo, FMRP levels increase in animals raised in a complex environment (Irwin et al. 2000b ) and in response to sensory stimulation (Todd & Mack 2000) ; both paradigms are thought to induce synaptic plasticity (Greenough et al. 1985 , Lendvai et al. 2000 . FMR1 mRNA is present in synaptoneurosome preparations thought to be highly enriched for synapses (Weiler et al. 1997) . Furthermore, stimulation with mGluR-specific agonists causes FMRP levels to increase significantly in these preparations. It is unclear whether this increase is specific for FMRP or if all mRNAs present at the synapse are translated after stimulation. While these data point to the involvement of FMRP in synaptic plasticity, one cannot yet infer a causative role.
The most direct evidence of FMRP's role in synaptic plasticity comes from recent studies comparing wild-type and knockout mice using two synaptic models for information storage: long-term depression (LTD) and long-term potentiation (LTP). LTD is a decrease in the strength of the same synapses after prolonged, low-frequency stimulation (Bear & Abraham 1996) . One form of LTD is mGluRdependent and requires protein synthesis (Huber et al. 2000) . This form of LTD is enhanced in Fmr1 KO mice (M.F. Bear, personal communication), constituting direct evidence that the absence of FMRP alters synaptic plasticity. LTP is a longterm increase in synaptic strength in response to high-frequency stimulation, and it is thought to have an early phase requiring neither transcription nor protein synthesis, an intermediate-mGluR-dependent-phase requiring only protein synthesis, and a late phase requiring transcription and protein synthesis (Bliss & Collingridge 1993 , Raymond et al. 2000 . Fmr1 knockout mice show no difference in either the early-or late-phase LTP (Godfraind et al. 1996 , Paradee et al. 1999 , but it remains to be seen if the intermediate, mGluR-dependent phase is affected. This evidence of altered synaptic plasticity along with spine maturation abnormalities in knockout mice, and both the RNA binding and protein translational capacities of FMRP lead to intriguing possibilities for the role of FMRP in synaptic function.
Protein synthesis has long been considered a necessary component of synaptic plasticity (Steward & Schuman 2001) , and for years there has been mounting evidence that specificity of synaptic plasticity is gained in part through local protein synthesis at individual synapses in dendrites. All the necessary machinery for protein synthesis is found at the site of synaptic contact: free polyribosomes and rough endoplasmic recticula are found in dendrites at the base of spines as are a number mRNAs (Steward & Levy 1982 , Steward & Reeves 1988 , Miyashiro et al. 1994 , Kuhl & Skehel 1998 . Furthermore, local protein synthesis occurs in live, transected dendrites (Torre & Steward 1992 , Aakalu et al. 2001 , in vitro in response to mGluR activation (Weiler & Greenough 1993) , and in both LTP and LTD (Kang & Schuman 1996 , Huber et al. 2000 . FMRP has been detected in dendrites and dendritic spines by immunogold labeling and electron microscopy, and it is thought to be associated with translating polyribosomes in dendrites (Feng et al. 1997b) . Taken together the above observations are compelling evidence that FMRP plays a role in protein synthesis-dependent synaptic plasticity.
FMRP's role in synaptic plasticity could take a number of turns after the FMRP mRNP leaves the nucleus. FMRP could be involved in the dendritic localization of its ligands and could influence the translation of those mRNAs either at the site of synapse or in the cell body (for a model of FMRP function in the neuron see Figure 3) . A recent study indicates that the dendritic mRNAs MAP2, CAMII kinase, dendrin, and ARC are not abnormally localized in Fmr1 KO mice (Steward et al. 1998) ; however, these mRNAs are not ligands for FMRP RNA binding (Brown et al. 2001) . Thus, though FMRP is not involved in localization of all dendritic mRNAs, it may still localize its specific ligands to the dendrites. In vivo ligands that are translationally altered by FMRP include a number of transcripts involved in synaptic function in both the pre-and postsynaptic cells (Brown et al. 2001) . For example, translation of both UNC-13 and SAPAP4 is downregulated in patient cell lines, and both genes appear to play a role in synaptic function. However, UNC-13 is involved in presynaptic vesicle fusion, whereas SAPAP4 is associated with PSD-95 at the postsynaptic density. Further study of the effects of altered translation of these transcripts and others should prove useful in elucidating the molecular mechanisms involved in the pathogenesis of fragile X syndrome.
The subtle effect of FMRP on translation and the transient nature of the spine phenotype are consistent with the phenotype seen in patients. It is clear that there is no global and fundamental defect in synapses of fragile X patients, because for the most part nervous system function in patients is normal. Furthermore, both patients and KO mice can learn to perform simple tasks with practice, so it appears that although higher-order thinking is impaired, basic cognitive function still remains. That Fmr1 KO mice show a change in one type of synaptic plasticity (LTD) and not in another (LTP) indicates that the loss of FMRP may not even affect an individual synapse under all conditions. Identifying at which synapses and under what conditions the loss of FMRP affects synaptic function should provide insight not only into the pathogenesis of fragile X, but also into learning and cognition in general.
TREATMENT
Current treatment modalities for fragile X syndrome are palliative and involve individually tailored behavioral and cognitive therapy designed to help each patient reach his maximum potential in conjunction with symptom-specific therapy for medical problems (for reviews see Hagerman & Cronister 1996) . Unfortunately, no molecular-based approach exists, and the difficulties of finding one are numerous. Because phenotypic consequences of the absence of FMRP are apparent so early after birth (Nimchinsky et al. 2001) , and these defects in synaptic plasticity could produce long-term neural wiring effects, any molecular treatment may need to be applied early. It also appears that any therapeutic approach may need to target downstream effects of FMRP function. Though full-mutation FMR1 expression can be reactivated with the use of methylation and histone deacetylase inhibitors, reactivation is slight, cellular toxicity is substantial, and transcripts with large repeats are not translated well (Feng et al. 1995 , Chiurazzi et al. 1999 , Coffee et al. 1999 , Kenneson et al. 2001 . Thus, reactivating transcription of FMR1 may not be enough to restore FMRP levels. FMRP replacement therapy may also have its downside, as overexpression of human FMRP in the mouse appears to cause a phenotype of its own (Peier et al. 2000) . The identification of the in vivo ligands of FMRP by Brown et al. (2001) opens the door for novel therapeutic approaches targeted downstream of FMRP that may avoid these difficulties. Translational changes, and any subsequent downstream effects, may prove to be more assayable markers for the fragile X phenotype than transient spine abnormalities. If a highthroughput assay of the phenotype can be established, one can screen combinatorial libraries for small molecules that rescue this phenotype and thus identify potential therapeutic agents for the treatment of fragile X syndrome (Lam 1997 Model of FMRP function in the neuron. FMRP is transported into the nucleus of neurons via its nuclear localization signal (1). Once in the nucleus FMRP associates with 4% of cellular mRNAs as well as a number of proteins to form a large RNP (2) that is subsequently transported out of the nucleus via the nuclear export signal of FMRP (3). Once in the cytoplasm the FMRP mRNP can either associate with ribosomes in the cell body (4) producing proteins (5) that can then be transported into the axon (6) or dendrites (7), or the FMRP mRNP can itself be transported into the dendrites (8) and associate with ribosomes to produce proteins, including its own message and others in response in part to mGluR activation (10). Both the local translation of protein in the dendrite and transport of proteins from the cell body mediate synaptic plasticity and spine maturation (11).
